In a longitudinal prospective cohort study by Nikkhoo et al., 208 confirmed COVID-19 patients were divided into two groups according to their IL-6 values ​​on the first day of hospitalization: high (n = 107) or non-high/normal (n = 101). The gene discussed is IL6; the disease is COVID-19.